Drugs / SOFINICLINE
SOFINICLINE
also known as
ABT-894 · A-422894.0 · A-422894.112 · Sofiniclina · SOFINICLINE BENZENESULFONATE · Sofinicline benzenesulphonate · Sofinicline besilate · Sofinicline besylate
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00548925 | Nov 2007 → Dec 2008 | diabetic polyneuropathy | AbbVie | Completed | No outcome recorded |
| Phase 2 | NCT00507936 | Aug 2007 → Oct 2008 | diabetic polyneuropathy, neuropathy, painful | AbbVie | Completed | No outcome recorded |
| Phase 2 | NCT00429091 | Jan → Aug 2007 | attention deficit-hyperactivity disorder | Abbott | Completed | No outcome recorded |
Evidence & citations 10 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SOFINICLINE | ChEMBL registry synonym — accepted as the source's own label CHEMBL238465 ↗ |
| Known as | A-422894.0 | ChEMBL registry synonym — accepted as the source's own label CHEMBL238465 ↗ |
| Known as | A-422894.112 | ChEMBL registry synonym — accepted as the source's own label CHEMBL238465 ↗ |
| Known as | ABT-894 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00548925 ↗ |
| Known as | Sofiniclina | ChEMBL registry synonym — accepted as the source's own label CHEMBL238465 ↗ |
| Known as | SOFINICLINE BENZENESULFONATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL238465 ↗ |
| Known as | Sofinicline benzenesulphonate | ChEMBL registry synonym — accepted as the source's own label CHEMBL238465 ↗ |
| Known as | Sofinicline besilate | ChEMBL registry synonym — accepted as the source's own label CHEMBL238465 ↗ |
| Known as | Sofinicline besylate | ChEMBL registry synonym — accepted as the source's own label CHEMBL238465 ↗ |
| Modality | Small molecule | — CHEMBL238465 ↗ |